JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD.

Jiangsu Bioperfectus Technologies Co., Ltd.

688399

CNE1000055B2

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/05/2024 BST			5-day change	1st Jan Change
74.86 ^CNY	+1.71%		+1.93%	+37.21%

04-26	Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-22	Bioperfectus Technologies Gets Nod to Register Hepatitis B Detection Kit	MT

Jiangsu Bioperfectus Technologies Co., Ltd.(XSSC:688399) added to S&P Global BMI Index

September 19, 2022 at 05:00 am

Latest news about Jiangsu Bioperfectus Technologies Co., Ltd.

Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Bioperfectus Technologies Gets Nod to Register Hepatitis B Detection Kit	03-22	MT
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Jiangsu Bioperfectus Technologies Co., Ltd.(XSSC:688399) dropped from S&P Global BMI Index	12-18	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
Bioperfectus Elects Chairman, General Manager	20/09/23	MT
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	18/10/22	CI
Jiangsu Bioperfectus Technologies Co., Ltd.(XSSC:688399) added to S&P Global BMI Index	19/09/22	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Test makers target monkeypox market as cases surge	03/06/22	RE
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI

Chart Jiangsu Bioperfectus Technologies Co., Ltd.

Duration

Period

Chart Jiangsu Bioperfectus Technologies Co., Ltd.

More charts

Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The Company mainly conducts its businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD.	+37.21%	599M
BIOMÉRIEUX	-0.80%	12.65B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.68%	8.01B
DIASORIN S.P.A.	+0.69%	5.35B
LANTHEUS HOLDINGS, INC.	+22.60%	5.23B
AUTOBIO DIAGNOSTICS CO., LTD.	+1.03%	4.69B
10X GENOMICS, INC.	-53.29%	3.26B
ANDON HEALTH CO., LTD.	+13.22%	2.64B
VITROLIFE AB	-7.55%	2.23B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-0.46%	1.94B